These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8363225)

  • 1. Effects of 15-deoxyspergualin on the expression of surface immunoglobulin in 70Z/3.12 murine pre-B cell line.
    Sterbenz KG; Tepper MA
    Ann N Y Acad Sci; 1993 Jun; 685():205-6. PubMed ID: 8363225
    [No Abstract]   [Full Text] [Related]  

  • 2. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation.
    Tepper MA; Nadler SG; Esselstyn JM; Sterbenz KG
    J Immunol; 1995 Sep; 155(5):2427-36. PubMed ID: 7650374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 15-deoxyspergualin on antibody secretion by specific isotypes producing B-cell hybridomas and myelomas.
    Sterbenz KG; Tepper MA
    Transplant Proc; 1994 Dec; 26(6):3218-20. PubMed ID: 7998121
    [No Abstract]   [Full Text] [Related]  

  • 4. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
    Tepper MA
    Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation.
    Wang B; Benoist C; Mathis D
    J Exp Med; 1996 Jun; 183(6):2427-36. PubMed ID: 8676063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells.
    Morikawa K; Oseko F; Morikawa S
    Transplantation; 1992 Sep; 54(3):526-31. PubMed ID: 1329279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyspergualin directly suppresses antibody formation in vivo and in vitro.
    Fujii H; Takada T; Nemoto K; Yamashita T; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1990 Feb; 43(2):213-9. PubMed ID: 1690194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.
    Kirkland TN; Qureshi N; Takayama K
    Infect Immun; 1991 Jan; 59(1):131-6. PubMed ID: 1898897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell-induced expression of membrane IgG by 70Z/3 B cells.
    Jacobs DH; Sneller MC; Misplon JA; Edison LJ; Kunimoto DY; Strober W
    J Immunol; 1986 Jul; 137(1):55-60. PubMed ID: 3086458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.
    Morikawa K; Nemoto K; Miyawaki T; Morikawa S
    Clin Exp Immunol; 1998 Jun; 112(3):495-500. PubMed ID: 9649221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and regulation of immunoglobulin expression in a murine pre-B cell line, 70Z/3. I. Cell cycle-associated induction of sIgM expression and kappa-chain synthesis in 70Z/3 cells by LPS stimulation.
    Sakaguchi N; Kishimoto T; Kikutani H; Watanabe T; Yoshida N; Shimizu A; Yamawaki-Kataoka Y; Honjo T; Yamamura Y
    J Immunol; 1980 Dec; 125(6):2654-9. PubMed ID: 6776197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-deoxyspergualin prevents mucosal injury by inhibiting production of TNF-alpha and down-regulating expression of MD-1 in a murine model of TNBS-induced colitis.
    Lee J; Kim MS; Kim EY; Park HJ; Chang CY; Jung DY; Kwon CH; Joh JW; Kim SJ
    Int Immunopharmacol; 2007 Aug; 7(8):1003-12. PubMed ID: 17570317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin alters the expression of different forms of immunoglobulin mu heavy chains and their associated proteins by pre-B cell lines and normal Ly-1 (CD5+) B cells.
    Chen J; Herzenberg LA; Herzenberg LA
    Int Immunol; 1991 Nov; 3(11):1117-27. PubMed ID: 1722112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.
    Giri JG; Kincade PW; Mizel SB
    J Immunol; 1984 Jan; 132(1):223-8. PubMed ID: 6418798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 15-deoxyspergualin on the induction of cytotoxic T lymphocytes and bone marrow suppression.
    Nishimura K; Tokunaga T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1104-7. PubMed ID: 2784883
    [No Abstract]   [Full Text] [Related]  

  • 17. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 18. [15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
    Kappos L; Theobald K; Hartung HP
    Nervenarzt; 1992 Dec; 63(12):768-71; discussion 772. PubMed ID: 1494394
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 15-deoxyspergualin on mononuclear cells from kidney recipients.
    Johansson-Borg A; Ohlman S; Groth CG
    Transplant Proc; 1992 Feb; 24(1):267-8. PubMed ID: 1539276
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of a xenogeneic mixed lymphocyte endothelial cell culture with 15-deoxyspergualin.
    Haisch CE; Lodge PA; Lamoureux C; Thomas FT
    Transplant Proc; 1992 Apr; 24(2):439-40. PubMed ID: 1566379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.